transition from semaglutide to tirzepatide Early Dose Escalation of after Switching in Type 2 Diabetes Mellitus Switching from Semaglutide to Tirzepatide:

There is currently no robust clinical data to suggest that combining semaglutide and liraglutide is safe or that it leads to better weight loss outcomes than using one medication at the correct dosage

Glucose management: monitoring Glycaemic management is primarily assessed with the HbA 1c test, which was the measure studied in trials demonstrating the benefits of glucose lowering [2]

Injectable semaglutide is administered subcutaneously once per week

10.1002/mds.29145 100 MeadeT

To correct for the impact of switching from study RBCs to non-study RBCs in patients who receive both types of RBCs, an inverse probability censoring weighting method will be used

Benefits: Immune support Useful for colds, flu & other infections *Higher doses of Vitamin C can be dehydrating